---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-021871"
form_type: "8-K"
ticker: "GH"
cik: "0001576280"
company_name: "Guardant Health, Inc."
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T11:03:57.794440+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Guardant Health director Samir Kaul resigns; board size reduced to 8

## Summary
- Samir Kaul resigned from the board and compensation committee, effective Feb 1, 2024.
- Resignation not due to any dispute or disagreement with the company or board.
- Board size reduced from nine to eight directors effective upon his resignation.

## SEC filing metadata
- accession: 0001193125-24-021871
- form_type: 8-K
- ticker: GH
- cik: 0001576280
- company_name: Guardant Health, Inc.
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576280/000119312524021871/0001193125-24-021871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576280/000119312524021871/d745810d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-021871
- JSON: https://secwatch.observer/filing/0001193125-24-021871.json
- Plain text: https://secwatch.observer/filing/0001193125-24-021871.txt

## Key facts
- Executive change
  Samir Kaul resigned as Director at Guardant Health, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 26, 2024, Mr. Samir Kaul notified the board of directors (the “Board”) of Guardant Health, Inc. (the “Company”) that he intends to resign as member of the Board and as a member of the compensation committee of the Board effective February 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312524021871/0001193125-24-021871-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.